CHM Price sensitive 10 Jun 2025, 12:20 PM

Chimeric receives $2.5 M advance on FY25 R&D tax incentive

Chimeric Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in